Advertisement

News

New agreement for side stream treatment in EU’s largest RAS salmon park

Biomega Group will produce human-grade protein products and salmon oil, together with high-quality pet food, from all the side streams arising from salmon harvesting at the site.

New agreement for side stream treatment in EU’s largest RAS salmon park
Photo caption: Stig Petersen, CEO of Biomega Group.
June 10, 2021

Biomega Group, a biosciences company producing high-quality ingredients for the global health and nutrition sectors, partnered with Quality Salmon Sotenäs AB, owned by Norwegian-owned Lighthouse Finance AS, to invest in Quality Salmon Industry Park, located in Sotenäs, Sweden.

Said to be the largest site of its kind in Europe, the circular and sustainable industrial park for the production of land-based Atlantic salmon will be fully integrated and is estimated to cost between €1.6 and €2 billion on completion. Quality Salmon previously partnered with Siemens, iCell Sustainable Nutrition and BioMar.

The new agreement states that Biomega will be a central contributor to the project securing sustainability and circularity at the park by producing human-grade protein products and salmon oil, together with high-quality pet food, from all the side streams arising from salmon harvesting at the site.

Stig Petersen, CEO of Biomega Group, stated that “Biomega is proud to be chosen as the preferred partner for valorizing salmon side streams at the Sotenäs park. It is an important next step on our growth journey and a testament to our business’ unique position as an innovation partner. We are tremendously excited about the opportunities Sotenäs will offer the business and look forward to a favorable collaboration with Quality Salmon Sotenäs AB and the other leading companies within the industrial park, including Siemens and Vattenfall. This is a great next step for Biomega right after the start of building our second biorefinery in Denmark, Hirtshals this year.”

Biomega aspires to become the leading partner for innovative high-quality ingredients to the health & nutrition industry and is driven by a fully sustainable business model. Biomega utilizes proprietary biotechnology to transform high-quality salmon raw material into hydrolyzed salmon proteins (salmon peptides), salmon meal and salmon oil, and has significant expansion plans in place to expand its product portfolio.

At Sotenäs, the company plans to build a new production facility to handle up to 39,000 metric tons of side stream materials when the industrial park is fully scaled to its planned capacity. This will generate more than 17,000 metric tons of premium products distributed across Biomega’s product range.

“The aquaculture industry is facing extensive change due to the growing activity in land-based salmon farming, and we are committed to research and development to drive the sustainability of the industry forward. The steady supply of high-quality side streams from the park will give Biomega a unique quality advantage in our production and, with the contribution of Biomega expertise and solutions, we will be able to further optimize both the quality and circularity of our offer to new levels, not previously seen in the industry,” added Petersen.

When fully developed, the 140-hectare industry park will produce up to 100,000 tons of Atlantic salmon per year. It will incorporate all the required infrastructure for salmon farming, harvesting and processing, handling of side stream products and water purification, and will be a completely circular bioeconomy in its own right.

 

Photo caption: Stig Petersen, CEO of Biomega Group.